D. Shen
Molecular Biology · with Gottesman · 2012
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Oncology — 12 citations into it
Whom D. Shen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from D. Shen's perspective
Ordered by how strongly the researchers D. Shen trusts endorse each paper. Same corpus, a different order for every researcher.
- The basics of epithelial-mesenchymal transition. (Journal of Clinical Investigation)
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs (Nature Cell Biology)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. (Cancer Research)
- A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations (Cell)
- MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. (Cancer Research)
- The epithelial–mesenchymal transition: new insights in signaling, development, and disease (Journal of Cell Biology)
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer (Oncogene)
- microRNA functions. (Annual Review of Cell and Developmental Biology)
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism (Proceedings of the National Academy of Sciences of the United States of America)